The relationship between the binding ability and the rate of activation of the complement component C1.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Immunology

• Publication date

  1980-09-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  PMID 7429549PMCID PMC1458229
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A simple method for the detection and assay of C1.

  1979cited by this paper
• Differential elution of Clq, Clr and Cls from human Cl bound to immune aggregates. Use in the rapid purification of Cl subcomponents.

  1979cited by this paper
• Activation of the first component of human complement (C1) by antibody-antigen aggregates.

  1978cited by this paper
• Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.

  1978cited by this paper
• Differences in activation of human and guinea pig complement by retroviruses.

  1978cited by this paper
• The reaction between the complement subcomponent C1q, IgG complexes and polyionic molecules.

  1978cited by this paper
• Reconstitution of C1 in native proenzyme form and its use in a quantitative C1 activation test.

  1977cited by this paper
• A simplified procedure for the purification of C1̄‐inactivator from human plasma Interaction with complement subcomponents C1̄r and C1̄s

  1977cited by this paper
• Enhanced autoradiographic detection of 32P and 125I using intensifying screens and hypersensitized film

  1977cited by this paper
• The first complement component: evidence for an equilibrium between C1s free in serum and C1s bound in the C1 complex.

  1977cited by this paper
• Functional affinity constants of the reaction between 125I-labelled C1q and C1q binders and their use in the measurement of plasma C1q concentrations.

  1977cited by this paper
• The structure and enzymic activities of the C1r and C1s subcomponents of C1, the first component of human serum complement.

  1977cited by this paper
• Interactions of radio-detoxified Escherichia coli endotoxin preparations with the complement system

  1977cited by this paper
• The mechanism of activation of the first component of complement by a univalent hapten-IgG antibody complex.

  1977cited by this paper
• Activation of C1r by proteolytic cleavage.

  1976cited by this paper
• The unactivated form of the first component of human complement, C1.

  1976cited by this paper
• Studies on the complement-binding site of rabbit immunoglobulin G-11. The reaction of rabbit IgG and its fragments with Clq.

  1974cited by this paper
• Isolation and characterization of the proenzyme form of the C1s subunit of the first complement component.

  1974cited by this paper
• Effect of chemical and enzymatic radioiodination on in vitro human Clq activities.

  1973cited by this paper
• Clq: rapid purification method for preparation of monospecific antisera and for biochemical studies.

  1971cited by this paper
• Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

  1971cited by this paper
• The cross-linking of proteins with glutaraldehyde and its use for the preparation of immunoadsorbents.

  1969cited by this paper
• THE ENZYMATIC NATURE OF C'1r

  1968cited by this paper
• ACTION OF THE FIRST COMPONENT OF COMPLEMENT. ACTIVITATION OF C'1 TO C'1A IN THE HEMOLYTIC SYSTEM.

  1964cited by this paper

• Defining the Features of Complement-Active IgM.

  2025cites this paper
• A C1 inhibitor ortholog from rock bream (Oplegnathus fasciatus): molecular perspectives of a central regulator in terms of its genomic arrangement, transcriptional profiles and anti-protease activities of recombinant peptide.

  2014cites this paper
• Recombinant expression of the autocatalytic complement protease MASP-1 is crucially dependent on co-expression with its inhibitor, C1 inhibitor.

  2013cites this paper
• Complement in Disease - Extracellular Proteins as Complement Regulators

  2011cites this paper
• Biological activities of C1 inhibitor.

  2008cites this paper
• Homozygous C1 inhibitor deficiency: The conclusion of a long search.

  2006cites this paper
• The pathophysiology of hereditary angioedema.

  2005cites this paper
• Initiation of complement activation

  2005cites this paper
• The first component of human complement (C1): Activation and control

  2004cites this paper
• The biological role of the C1 inhibitor in regulation of vascular permeability and modulation of inflammation.

  2004cites this paper
• Ig N-glycan orientation can influence interactions with the complement system.

  1997cites this paper
• beta-Amyloid activates complement by binding to a specific region of the collagen-like domain of the C1q A chain.

  1994cites this paper
• Human antibody effector function.

  1992cites this paper
• Mechanisms of oligodendrocyte interaction with normal human serum--defining the role of complement.

  1992cites this paper
• Complement activation by immunoglobulin does not depend solely on C1q binding

  1990cites this paper
• Human monoclonal IgG isotypes differ in complement activating function at the level of C4 as well as C1q

  1988cites this paper
• IMPORTANCE OF ANTIGEN SPECIFICITY FOR COMPLEMENT‐MEDIATED LYSIS BY MONOCLONAL ANTIBODIES

  1988cites this paper
• The Molecular Basis of the Interaction of Immunoglobulin G with Complement and Phagocytic Cells

  1988cites this paper
• C1 inhibitor and hereditary angioneurotic edema.

  1988cites this paper
• Interaction of fibronectin with DNA/anti-DNA complexes from systemic lupus erythematosus: role of activated complement Cl in modulation of the interactions.

  1988cites this paper
• Synergistic complement lysis by monoclonal antibodies to the human leukocyte common antigen requires both the classical and alternative pathways.

  1987cites this paper
• Activation of human C1: analysis with Western blotting reveals slow self-activation.

  1987cites this paper
• Chapter 1 Structure and function of antibodies

  1987cites this paper
• Activation of complement by soluble IgG aggregates and their subsequent interaction with macrophages.

  1987cites this paper
• Opsonic and Complement‐Dependent Bactericidal Activities of Various Immunoglobulin Preparations for Intravenous Use

  1986cites this paper
• The functional inhibition of activated C1 inhibitor in normal human serum causes spontaneous consumption of the complement components C2, C3, C4, and factor B.

  1986cites this paper
• Is IgM-like dislocation a common feature of antibody function?

  1986cites this paper
• Activation of hemolytic complement by mouse monoclonal IgG1 antibody: comparison with rabbit IgG.

  1985cites this paper
• [Acquired C1 esterase inhibitor deficiency and lymphoproliferative syndromes].

  1985cites this paper
• Co-operative interaction of subcomponents of the first component of complement with IgG: a functional defect of dimeric Facb from rabbit IgG.

  1985cites this paper
• Effector functions of a monoclonal aglycosylated mouse IgG2a: binding and activation of complement component C1 and interaction with human monocyte Fc receptor.

  1985cites this paper
• Antibody density on rat red cells determines the rate of activation of the complement component Cl

  1985cites this paper
• The classical complement pathway: activation and regulation of the first complement component.

  1985cites this paper
• Déficit acquis en inhibiteur de la C1 estérase et syndrome lymphoprolifératif

  1985cites this paper
• Antibody density on rat red cells determines the rate of activation of the complement component C1.

  1985cites this paper
• Complement

  1985influential citation
• Complement C1q binding affects spin-labeled heterosaccharides of rabbit antibodies in immune but not artificial immunoglobulin G aggregates.

  1984cites this paper
• Antibody-independent C1 activation by E. coli.

  1984cites this paper
• Interaction of C1q with beta 2-microglobulin.

  1984cites this paper
• Activation and regulation of the first complement component.

  1983cites this paper
• C1q binding and C1 activation by various isolated cellular membranes.

  1983cites this paper
• Binding and activation of C1 by cell bound IgG: activation depends on cell surface hapten density.

  1983cites this paper
• Structural studies on DNP binding antibodies

  1983cites this paper
• Immunoglobulin M Conformational Change is a Signal for Complement Activation

  1983cites this paper
• The binding and activation of the Clr-Cls subunit of the first component of human complement.

  1982cites this paper
• Structural features of the first component of human complement, C1, as revealed by surface iodination.

  1982cites this paper
• Staphylococcal protein A fluoroimmunoassay for immune complexes.

  1982cites this paper
• Interaction of C1q with DNA.

  1982cites this paper
• Characterization of various immunoglobulin preparations for intravenous application. II. Complement activation and binding to staphylococcus protein A.

  1982cites this paper
• The classical complement pathway: mechanism of activation of the first component by antigen-antibody complexes.

  1982cites this paper
• Interaction of Clq with DNA

  1982cites this paper
• Functional affinity constants of subfragments of immunoglobulin G for Clq.

  1982cites this paper
• Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates.

  1982cites this paper
• Formation of complement subcomponent C1q-immunoglobulin G complex. Thermodynamic and chemical-modification studies.

  1982cites this paper
• Cutaneous localization of the membrane attack complex in discoid and systemic lupus erythematosus.

  1982cites this paper
• A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement.

  1982cites this paper